In addition, investigations using matched multi-omics datasets from the same individuals (e.g., paired transcriptomic and metabolomic profiles) will be critical for clarifying the potential biomarker roles and molecular mechanisms of FEN1, FADS1, FADS3, RAB3IL1 and NRBP1 in CRC. This evidence concerns the gene FADS3 and colorectal carcinoma.